The perils of doing business in China have come into focus again recently, with allegations that staff from the British pharmaceutical giant GlaxoSmithKline paid $500 million in bribes over several years. Four executives from GlaxoSmithKline were arrested in July, while its British-born head of China operations has been prevented from leaving the country. There are … Continue reading Australians face perils by doing business in China